Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cells Bernard T. FrenchDawn E. PatrickRonald W. Trewyn Original Articles Pages: 171 - 177
Celiptium-induced nephrotoxicity and lipid peroxidation in rat renal cortex Christine DadounGilda Raguenez-Viotte Original Articles Pages: 178 - 186
Porfiromycin disposition in oxygen-modulated P388 cells Su-Shu Pan Original Articles Pages: 187 - 193
Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluation Peter Buhl JensenHenrik RoedMogens Spang-Thomsen Original Articles Pages: 194 - 198
Mechanism of tumor cell killing by HO-221, a novel antitumor compound Tsunetaka NakajimaTadao OkamotoTetsuo Taguchi Original Articles Pages: 199 - 204
Metabolism and elimination of rhodamine 123 in the rat Trevor W. SweatmanRamakrishnan SeshadriMervyn Israel Original Articles Pages: 205 - 210
Cisplatin-induced reductions in renal functional reserve uncovered by unilateral nephrectomy: an experimental study in the pig Mike E. C. RobbinsDarryl CamplingAdam Michalowski Original Articles Pages: 211 - 218
Doxorubicin and doxorubicinol: intra-and inter-individual variations of pharmacokinetic parameters Jeanne-Marie JacquetFrançoise BressolleJean-François Rossi Original Articles Pages: 219 - 225
The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity William E. FitzsimmonsRichard GhalieHerbert Kaizer Original Articles Pages: 226 - 228
Carboplatin and etoposide in advanced lung cancer: — a phase I study K. LiippoV. NikkanenE. Heinonen Original Articles Pages: 229 - 233
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency Robert J. MotzerDonna NiedzwieckiGeorge J. Bosl Original Articles Pages: 234 - 238
Carboplatin in malignant mesothelioma: A phase II study of the cancer and leukemia Group B Nicholas J. VogelzangMaria GoutsouMark R. Green Original Articles Pages: 239 - 242
High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group David R. GandaraEdith A. PerezRobert W. Carlson Original Articles Pages: 243 - 247
DNA binding of iproplatin and its divalent metabolitecis-dichloro-bis-isopropylamine platinum(II) L. PendyalaA. V. ArakaliP. J. Creaven Short Communication Pages: 248 - 250
Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer Hiroshi SaitoKaoru ShimokataHidehiko Saito Short Communication Pages: 251 - 252